0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight ovarian cancer treatment landscape competitive analysis 2017.Your search for "" gave back 1532458 results.
In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Polycystic Ovarian...
Catalog:
9Dimen Research
May 2022
Price: USD 3,200.00
PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP). They are developed for multiple...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H1 2018 Summary Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Histone deacetylase 1...
Catalog:
Global Markets Direct
March 2018
Price: USD 3,500.00
RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1) - Pipeline Review, H2...
Catalog:
Global Markets Direct
November 2018
Price: USD 3,500.00
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Cancer Supportive Care market size was valued at US$ 21650 million in 2023. With growing demand in downstream market, the Cancer...
Catalog:
LPI
February 2024
Price: USD 3,660.00
RAC Gamma Serine/Threonine Protein Kinase (Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1) - Pipeline...
Catalog:
Global Markets Direct
February 2018
Price: USD 3,500.00
Aurora Kinase A - Pipeline Review, H2 2019 Summary According to the recently published report 'Aurora Kinase A - Pipeline Review, H2 2019...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Pipeline Review, H2 2018 Summary Cellular Tumor...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
The global PARP (Poly ADP-Ribose Polymerase) Inhibitor market size was valued at US$ 4584.5 million in 2023. With growing demand in downstream market...
Catalog:
LPI
January 2024
Price: USD 3,660.00
PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP). They are developed for multiple...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Gynecological Cancers Therapeutics refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Publisher' newest research report, the “Oncolytic Virus Drug Treatment Industry Forecast” looks at past sales and reviews total world Oncolytic...
Catalog:
LPI
January 2023
Price: USD 3,660.00
RAC Gamma Serine/Threonine Protein Kinase (Protein Kinase Akt 3 or Protein Kinase B Gamma or RAC PK Gamma or STK 2 or AKT3 or EC 2.7.11.1) - Pipeline...
Catalog:
Global Markets Direct
August 2018
Price: USD 3,500.00
